

Cover Story
The Centers for Medicare and Medicaid Services appear to be executing a two-step strategy to shrink the $8 billion annual price tag of clinical diagnostic laboratory tests.
By Matthew Bin Han Ong
In Brief


Funding Opportunities
Drugs & Targets


Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - CBER Director Vinay Prasad dared to “say no to drugs”
- Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- Forty years after Chernobyl: Little evidence to show that radiation released from the accident increased cancers globally
- Kennedy hints at intended USPSTF reforms at Senate Finance Committee hearing











